Verrica Parmaceuticals 주식 가격. VRCA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

0.80

매수가

0.78

매도가

0.81

거래량

286,274

0.8495 일간 변동폭 0.92

0.7043 52주 범위 11.41

market_cap

36.481M

전일 종가

0.89

개장가

0.89

최근 거래 시간

1376

0.8

(formt)

마지막 거래 시간

재정 규모

US$ 255,528

VWAP

0.892601

평균 볼륨(3m)

950,469

발행 주식

45,600,795

배당수익률

주가수익률

-0.61

주당순이익(EPS)

-1.47

매출

5.12M

순이익

-67M

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. 더 보기

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.verrica.com

본부

Wilmington, Delaware, USA

설립됨

Verrica Parmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker VRCA. The last closing price for Verrica Parmaceuticals was US$0.89. Over the last year, Verrica Parmaceuticals shares have traded in a share price range of US$ 0.7043 to US$ 11.41.

Verrica Parmaceuticals currently has 45,600,795 shares in issue. The market capitalisation of Verrica Parmaceuticals is US$40.58 million. Verrica Parmaceuticals has a price to earnings ratio (PE ratio) of -0.61.

Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.11	-12.0879120879	0.91	0.94	0.71	370383	0.86646491	CS
4	-0.79	-49.6855345912	1.59	1.7382	0.7043	769208	0.96308564	CS
12	-1.68	-67.7419354839	2.48	2.52	0.7043	950469	1.5284916	CS
26	-7.84	-90.7407407407	8.64	9.395	0.7043	676770	2.64786932	CS
52	-2.7	-77.1428571429	3.5	11.41	0.7043	664826	4.35252803	CS
156	-11.275	-93.3747412008	12.075	12.075	0.7043	366395	4.45744156	CS
260	-13.47	-94.3938332165	14.27	18.67	0.7043	260063	5.52956532	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
FBRXForte Biosciences Inc	US$ 13.60 (129.53%)	28.92M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	279.33M
XCURExicure Inc	US$ 11.01 (89.18%)	22.91M
AGFYAgrify Corporation	US$ 37.4635 (68.00%)	921.45k
SLXNSilexion Therapeutics Corporation	US$ 0.3495 (54.51%)	198.66M
SKKSKK Holdings Limited	US$ 4.55 (-47.28%)	816.93k
QMMMQMMM Holdings Limited	US$ 0.713999 (-43.78%)	4.61M
XTKGX3 Holdings Company Ltd	US$ 0.0901 (-37.82%)	5.95M
PRFXPainReform Ltd	US$ 1.02 (-27.14%)	5.09M
GLEGlobal Engine Group Holding Ltd	US$ 3.81 (-26.59%)	230.23k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.191 (17.39%)	662.68M
DBGIDigital Brands Group Inc	US$ 0.1345 (15.35%)	326.45M
NVDANVIDIA Corporation	US$ 145.89 (-0.76%)	309.57M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	283.09M
SLXNSilexion Therapeutics Corporation	US$ 0.3495 (54.51%)	200.06M